- Report
- January 2026
- 196 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- August 2025
- 184 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- March 2026
- 285 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- March 2026
- 193 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- March 2026
- 197 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- January 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- October 2025
- 160 Pages
Global
From €3005EUR$3,358USD£2,625GBP
€3536EUR$3,950USD£3,088GBP
- Report
- March 2025
- 270 Pages
Global
From €4296EUR$4,799USD£3,752GBP
- Report
- June 2022
- 200 Pages
Global
From €4296EUR$4,799USD£3,752GBP
Hot Melt Extrusion (HME) is a process used in drug discovery to produce drug-loaded polymeric materials. It is a continuous process that involves melting and mixing of polymers and active pharmaceutical ingredients (APIs) at high temperatures. The resulting material is then extruded through a die to form a solid product. HME is used to produce drug-loaded polymeric materials with improved bioavailability, solubility, and stability. It is also used to produce drug-loaded polymeric materials with controlled release profiles.
HME is a cost-effective and efficient method for producing drug-loaded polymeric materials. It is also a versatile process that can be used to produce a wide range of drug-loaded polymeric materials.
Some companies in the Hot Melt Extrusion market include Elmarco, Thermo Fisher Scientific, and GEA Group. Show Less Read more